- Report
- April 2025
- 50 Pages
Global
From €2503EUR$2,650USD£2,129GBP
Trovafloxacin is an antibiotic used to treat a variety of bacterial infections. It belongs to a class of antibiotics known as fluoroquinolones, which work by inhibiting the growth of bacteria. Trovafloxacin is used to treat a wide range of infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and sexually transmitted diseases. It is also used to treat certain types of pneumonia. Trovafloxacin is generally well tolerated, but can cause side effects such as nausea, vomiting, and diarrhea.
The Trovafloxacin market is highly competitive, with a number of companies offering the drug. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and AstraZeneca. These companies are constantly innovating and developing new formulations of Trovafloxacin to meet the changing needs of patients. Show Less Read more